Caidya
Caidya is designed to adapt and grow with biopharma innovators. We bring flexibility, and transparency – delivering tailored, proactive solutions from protocol development to study closeout. Our specialized expertise in therapeutics, operations, regulatory, and delivery yields the high-quality data you need for informed decision-making, ensuring that your projects stay on track.
Locations
- Africa
- APAC
- Australia
- Europe
- North America
- South America
Therapeutic Areas
- Cardiovascular
- Cell and Gene Therapy
- CNS
- Dermatology
- Diabetes
- Endocrinology
- Gastroenterology
- Genetic Diseases
- Hematology
- Immunology
- Infectious Diseases
- Inflammation
- Internal Diseases
- Metabolic Diseases
- Nephrology
- Neurology
- Nutrition and Health
- Oncology
- Ophthalmology
- Orthopedics
- Pain / Anesthesia
- Pediatrics / Neonatology
- Psychiatry
- Pulmonary
- Rare Disease
- Respiratory
- Rheumatology
- Vaccines
- Women's Health
Unique medical challenges call for tailored and adaptable solutions. Caidya is aligned with the rapid change inherent to biopharma innovators and equipped to help you navigate the drug development process.
And we think a little differently here at Caidya. We listen to clients – prioritizing your goals as we partner together to bring life-changing new therapies to the global community. Our culture and structure empower our teams to build personalized, patient-centric solutions that deliver studies efficiently and effectively. An ownership mentality – including access to executive leadership – and the expertise and willingness to be flexible produce the agility required to navigate complex clinical trials at the speed of your innovation.
And our results speak for themselves. In oncology trials, we deliver “site activation to close times” 60%+ faster than industry average and “days from trial activation to close times” that are 25%+ faster than industry average. Our success in conducting clinical trials is a product of deep medical, scientific, and operational expertise.
Caidya’s well tenured project management team boasts of therapeutic experience aligned with the clients we serve, including oncology at over 95%, rare disease and pediatrics at 70%, over 66% in cardiovascular and significant experience and focus in several other fast-growing areas, like hematology, dermatology and ophthalmology.
Our distinct global reach – conducting studies in over 50 countries and regions – empowers us to reach patients no matter where they are in the world. We enrich our strong presence in the Americas and Europe, with an APAC footprint, especially in China, which rivals many top 10 CROs.
From protocol development and study conduct to closeout and regulatory approval we operate as a proactive extension of your team, communicating transparently to preemptively solve issues to reduce project risks, and deliver the high-quality data you need for informed decision-making. Side by side with you – and with a vision for the future – we ensure your projects meet today’s needs, while preparing for tomorrow’s demands. That’s why companies that work with Caidya stay with Caidya.